GLP-1 Receptor Agonists and the Path to Sustainable Obesity Care
Wellbutrin is FDA-approved and commonly prescribed to manage major depressive disorder ( Wellbutrin is also prescribed off-label for other conditions, including attention deficit hyperactivity disorder (ADHD), obesity, bipolar disorder associated with depression, and sexual dysfunction caused by antidepressants
Retatrutide is a triple agonist that adds glucagon-receptor (GCGR) activity to the GLP-1 and GIP activity that tirzepatide already has
Going viral: a systematic review of google trends in plastic surgery and a recommended framework for its use
For users who want a more comprehensive system, the Nautilus HumanSport Freedom Trainer offers seven cable-based machines with dual weight stacks in a single integrated unit, making it one of the most complete strength solutions available for home use
In a 24-week clinical trial, a 7.5/46 mg dose led to an average loss of 9.0 kg (19.8 lbs)